Abstract:Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts, white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is a critical cause of neuronal loss and synaptic disintegration. Abnormal neuroinflammation, autophagy and apoptosis are the prerequisite factors for endothelial and neuronal cell damage. This leads to the onset and progression of cerebrovascular disorders and cognitive dysfunction. The innate immune cells, pattern recognition receptors, Toll-like receptor-4 and related inflammatory mechanisms disrupt cerebrovascular integrity via glial activation and increased pro-inflammatory interleukins and TNFα. Inflammasome polymorphisms and multi-faceted neuro-immune interactions further integrate systemic and central inflammatory pathways, which induce vascular tissue injury and neurodegeneration. Specifically, chronic cerebral hypoperfusion disrupts the self-cannibalization mechanism of autophagy via altered expression of autophagy-specific proteins, Beclin-1, LC3 and P62. The deregulated autophagy pathway causes neuronal loss, hippocampal shrinkage, and ultimate loss in synaptic plasticity. The vascular dementia models typically exhibit downregulated anti-apoptotic Bcl-2 and upregulated pro-apoptotic Bax, cleaved caspase-3, and cleaved-PARP levels in the brain, for which modulated p38 MAPK and JNK phosphorylation pathways play a vital role. Endoplasmic stress-induced apoptosis, calcium overload and glutamate excitotoxicity in combination with ASK1-MAPK signaling mechanism also contribute to the cerebrovascular pathology. Vascular injury reduces neurological scores and increases the infarct volume, DNA damage and neuronal apoptosis in ischemia/reperfusion injury. Additionally, synergistic and additive interactions between inflammasome, autophagy and apoptotic signaling pathways augment symptoms of vascular neurodegeneration. Overall, the current review enlightens the key risk factors and underlying mechanism triggering vascular dementia. The review additionally informs the challenges associated while treating vascular dysfunction, and highlights the need for targeted drugs for reducing cerebrovascular damage.

Atherosclerosis: The Culprit and Co-victim of Vascular Dementia

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Inflammation, apoptosis and autophagy as critical players in vascular dementia

Vascular Contributions to Healthy Aging and Dementia

Alzheimer's Disease and "the Vascular Hypothesis":Coincidence or Accomplice?

Vascular contributions to Alzheimer's disease

Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles

Pharmacological Treatment of Vascular Dementia: A Molecular Mechanism Perspective

Cerebral Small Vessel Disease and Alzheimer&rsquo;s Disease

Molecular biomarkers for vascular cognitive impairment and dementia

Vascular dysfunction associated with type 2 diabetes and Alzheimer's disease: a potential etiological linkage

Vascular Dementia: From Pathobiology to Emerging Perspectives

Vascular Dementia: A Microglia's Perspective.

The vascular contribution of apolipoprotein E to Alzheimer's disease

Impact of Atherosclerosis-Related Small Cerebral Vessel Damages on Tau Pathology in Atherosclerosis Mouse Model

The relationship between atherosclerosis and dementia

Review: Vascular dementia: clinicopathologic and genetic considerations

Comorbid Amyloid with Cerebrovascular Disease in Domain-Specific Cognitive and Neuropsychiatric Disturbances: a Cross-Sectional Memory Clinic Study

Alzheimer’s Disease and Vascular Aging

Hypercholesterolemia and the Increased Risk of Vascular Dementia: a Cholesterol Perspective

The Correlation Between Vascular Risk Factors and Alzheimer's Disease